B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers

Last updated: August 3, 2024
Sponsor: Sohag University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Cancer

Squamous Cell Carcinoma

Carcinoma

Treatment

Immunohistochemical staining

Clinical Study ID

NCT06536946
Soh-Med-25-05-07MS
  • All Genders

Study Summary

Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • tissue blocks with sufficient materials Cases with sufficient data

Exclusion

Exclusion Criteria:

  • tissue blocks with insufficient and necrotic materials. Casas with insufficient data

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Immunohistochemical staining
Phase:
Study Start date:
June 01, 2024
Estimated Completion Date:
September 30, 2025

Study Description

Skin cancer is one of the most common form of cancer worldwide. Cutaneous squamous cell carcinoma is one of most common skin tumers that caused by many factors as ultra violet ,ionizing radiation and others . It was an advanced spectrum ranging from actinic keratosis to invasive and metastatic squmous cell carcinoma. Correct identification of cutaneous squamous cell carcinoma is a challenge as it has both clinically and histopathologically mimickers.

So the aim of this study is to identify the expression of B-catenin in cutaneous Squamous cell carcinoma and its mimickers.

Connect with a study center

  • Sohag University hospital

    Sohag,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.